Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey ; day:14 ; month:12 ; year:2020 ; pages:1-14
Advances in therapy ; (14.12.2020), 1-14
- Urheber
-
Olson, Amy
Hartmann, Nadine
Patnaik, Padmaja
Wallace, Laura
Schlenker-Herceg, Rozsa
Nasser, Mouhamad
Richeldi, Luca
Hoffmann-Vold, Anna-Maria
Cottin, Vincent
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01578-6
- URN
-
urn:nbn:de:101:1-2021012119285811439573
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olson, Amy
- Hartmann, Nadine
- Patnaik, Padmaja
- Wallace, Laura
- Schlenker-Herceg, Rozsa
- Nasser, Mouhamad
- Richeldi, Luca
- Hoffmann-Vold, Anna-Maria
- Cottin, Vincent
- SpringerLink (Online service)
Ähnliche Objekte (12)
The natural history of progressive fibrosing interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial Fluid Behavior and Diseases
Interstitial lung diseases in children
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
The natural history of progressive fibrosing interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial Fluid Behavior and Diseases
Interstitial lung diseases in children
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
The natural history of progressive fibrosing interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial Fluid Behavior and Diseases
Interstitial lung diseases in children
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
Interstitial lung diseases in the hospitalized patient